Bronchogen
Also known as: Ala-Glu-Asp-Leu · AEDL
A tetrapeptide bioregulator for bronchial function, prescribed for COPD, asthma, and post-viral lung scarring.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~30 minutes
10 mg daily (oral, cycled)
Oral capsule
Mechanism of Action
Activates bronchial epithelial gene expression to rebuild damaged airways and restore local immune defenses.
Key Research Areas
Frequently Asked Questions
What is Bronchogen?▾
How does Bronchogen work?▾
What is the recommended dosage for Bronchogen?▾
What is the half-life of Bronchogen?▾
Is Bronchogen FDA approved?▾
Ready to get started with Bronchogen?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about Bronchogen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.